ATOM_local Ablative Therapy
NCT01941654
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
NSCLC
Activating EGFR Mutation
Interventions
RADIATION:
preemptive local ablative therapy
DRUG:
Oral TKI
Sponsor
Chinese University of Hong Kong
Collaborators
[object Object]